Quantcast
Home > Quotes > FWP
FWP

Forward Pharma A/S American Depositary Shares (FWP) Quote & Summary Data

$2.16
*  
0.03
1.37%
Get FWP Alerts
*Delayed - data as of May 18, 2018  -  Find a broker to begin trading FWP now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 2.19 / $ 2.06
Share Volume
9,946
50 Day Avg. Daily Volume
113,674
Previous Close
$ 2.19
52 Week High / Low
$ 30 / $ 1.63
Market Cap
101,917,438
Annualized Dividend
$ 23.07
Ex Dividend Date
9/12/2017
Dividend Payment Date
9/11/2017
Current Yield
1,003.17 %
Beta
-1.21

Intraday Chart

News for FWP

Shares Traded

Share Volume:
9,946
50 Day Avg. Daily Volume:
113,674

Trading Range

The current last sale of $2.16 is 32.52% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.19 $ 30
 Low: $ 2.06 $ 1.63

Company Description (as filed with the SEC)

Forward Pharma A/S is a Danish biopharmaceutical company that until recently was actively developing FP187®, a proprietary formulation of DMF, for the treatment of MS and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders. On February 1, 2017, our License Agreement with Biogen became effective. Pursuant to the License Agreement, Biogen paid us a non-refundable cash fee of $1.25 billion. The License Agreement provides Biogen with a co-exclusive license in the U.S. (which will be converted into an exclusive license if certain conditions are met within the time period set forth in the License Agreement), and an exclusive license outside the U.S., to the Company's intellectual property. For more information, see "--B. Business Overview--Our Company--License Agreement with Biogen.  ... More ...  

Risk Grade

Where does FWP fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 2.19
Open Date:
May 18, 2018
Close Price:
$ 2.16
Close Date:
May 18, 2018

Consensus Recommendation

Analyst Info